Branch Retinal Vein Occlusion With Macular Edema (DBCOND0078116)

Identifiers

Synonyms

Branch retinal vein occlusion with macular edema / Branch retinal vein occlusion with macular edema (disorder)

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Aflibercept	A vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular Degeneration (AMD), various types of macular edema and diabetic retinopathy, and metastatic colorectal cancer	Vascular endothelial growth factor A, long formtarget Placenta growth factortarget Vascular endothelial growth factor Btarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT03892434	Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO	Bevacizumab Dexamethasone	treatment	4	unknown_status
NCT03405376	Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion	Aflibercept	treatment	4	unknown_status
NCT02556723	Intravitreal Injections of Ziv-aflibercept for Macular Diseases	Aflibercept	treatment	Not Available	completed
NCT02006147	Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO	No drug interventions	treatment	1 / 2	completed
NCT03709745	Eylea and Lucentis for Macular Edema in Branch Retinal Vein Occlusion	Aflibercept Ranibizumab	treatment	4	unknown_status